Search research articles
Contact Us
Filters
Showing results (91-100 of 103) with videos related to
Page
of 11
Sort By:
Clinical Hemorheology and Microcirculation
|
July 20, 2004
Endothelium and hemorheology
V Turchetti, L Boschi, G Donati, et al.
Cancer Research
|
August 17, 2001
Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K
M Sun, J E Paciga, R I Feldman, et al.
Nature Genetics
|
February 13, 1999
Activating SRC mutation in a subset of advanced human colon cancers
R B Irby, W Mao, D Coppola, et al.
Endocrine-Related Cancer
|
November 8, 2014
Phase II clinical trial of pasireotide long-acting repeatable in patients with metastatic neuroendocrine tumors
M Cives, P L Kunz, B Morse, et al.
Environmental Science and Pollution Research International
|
February 11, 2014
Could feeding habit and migratory behaviour be the causes of different toxicological hazard to cetaceans of Gulf of California (Mexico)?
M C Fossi, C Panti, L Marsili, et al.
British Journal of Pharmacology
|
February 5, 2013
The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis
B Romano, F Borrelli, I Fasolino, et al.
Oncogene
|
February 21, 2024
Editorial Expression of Concern: Adenomatous polyposis coli (APC) regulates miR17-92 cluster through β-catenin pathway in colorectal cancer
Y Li, M Lauriola, D Kim, et al.
Endocrine-Related Cancer
|
April 16, 2016
A phase II study of axitinib in advanced neuroendocrine tumors
J R Strosberg, M Cives, J Hwang, et al.
Oncogene
|
January 29, 2013
Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer
W Kong, L He, E J Richards, et al.
Oncogene
|
October 30, 2013
Aurora-A is a determinant of tamoxifen sensitivity through phosphorylation of ERα in breast cancer
X Q Zheng, J P Guo, H Yang, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 103) with videos related to
Sort By:
Page
of 11
Clinical Hemorheology and Microcirculation
|
July 20, 2004
Endothelium and hemorheology
V Turchetti, L Boschi, G Donati, et al.
Cancer Research
|
August 17, 2001
Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K
M Sun, J E Paciga, R I Feldman, et al.
Nature Genetics
|
February 13, 1999
Activating SRC mutation in a subset of advanced human colon cancers
R B Irby, W Mao, D Coppola, et al.
Endocrine-Related Cancer
|
November 8, 2014
Phase II clinical trial of pasireotide long-acting repeatable in patients with metastatic neuroendocrine tumors
M Cives, P L Kunz, B Morse, et al.
Environmental Science and Pollution Research International
|
February 11, 2014
Could feeding habit and migratory behaviour be the causes of different toxicological hazard to cetaceans of Gulf of California (Mexico)?
M C Fossi, C Panti, L Marsili, et al.
British Journal of Pharmacology
|
February 5, 2013
The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis
B Romano, F Borrelli, I Fasolino, et al.
Oncogene
|
February 21, 2024
Editorial Expression of Concern: Adenomatous polyposis coli (APC) regulates miR17-92 cluster through β-catenin pathway in colorectal cancer
Y Li, M Lauriola, D Kim, et al.
Endocrine-Related Cancer
|
April 16, 2016
A phase II study of axitinib in advanced neuroendocrine tumors
J R Strosberg, M Cives, J Hwang, et al.
Oncogene
|
January 29, 2013
Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer
W Kong, L He, E J Richards, et al.
Oncogene
|
October 30, 2013
Aurora-A is a determinant of tamoxifen sensitivity through phosphorylation of ERα in breast cancer
X Q Zheng, J P Guo, H Yang, et al.
Page
of 11